Trial Profile
Phase 1 trial of CBT-101 in patients with Met-positive Advanced Non-Small Cell Lung Cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2017
Price :
$35
*
At a glance
- Drugs CBT 101-Carlbiotech (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 03 Oct 2017 New trial record